Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option
Crossref DOI link: https://doi.org/10.1038/eye.2016.174
Published Online: 2016-08-26
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ashraf, M
Souka, A
Adelman, R
Forster, S H
Text and Data Mining valid from 2016-08-26
Article History
Received: 24 April 2016
Accepted: 13 June 2016
First Online: 26 August 2016
Competing interests
: The authors declare no conflict of interest.